… of the digestive tract where dysbiosis of autochthonous intestinal microbiota, environmental
factors and host genetics are implicated in the disease development, severity, course and …

Inflammatory bowel disease (IBD), comprising Crohn’s disease (CD) and ulcerative colitis (UC),
is a heterogeneous state of chronic intestinal inflammation with no exact known cause. …

… accepted risk factor for the development and progression of CD… in terms of UC development
and disease course in male … to the development of IBD and disease complications. There …

… This manuscript pointed out some of the discoveries and developments made in the field of
main anti-inflammatory and immunomodulatory drugs currently used in IBD. To sum it up, we …

… The global epidemiology of inflammatory bowel disease has … incidence of inflammatory
bowel disease in developing nations … rates within the inflammatory bowel disease cohort have …

… Inflammatory bowel disease (IBD), as a global disease, has attracted much research interest.
Constant research has led to a better understanding of the disease … patients may develop …

… The findings of IBD genetic research may help clinical practices identify the subphenotype
of IBD and predict the disease development and prognosis, allowing for the detection of …

… fold increased risk of developing ulcerative colitis (UC) in patients with high intake of the n-6
PUFA LA. Furthermore, this study showed a 77% risk reduction in developing UC in patients …

… inflammation and coronary plaque (51). Anxiety and mental stress are associated with the
development … , including higher risk for disease development, disease progression, and poor …

… have essential functions in the development of many digestive diseases. Inflammatory bowel
disease (IBD) is a chronic non-specific inflammatory disease with a complex etiology, the …